What Is Metformin?
Metformin (brand names: Glucophage, Glumetza, Fortamet) is an oral medication used primarily to treat type 2 diabetes. It belongs to a drug class called biguanides and has been in clinical use since the 1950s. Today, it is the most widely prescribed diabetes medication in the world and the recommended first-line treatment in virtually every major clinical guideline.
How Metformin Works
Unlike many diabetes medications, Metformin does not stimulate the pancreas to produce more insulin. Instead, it works through three complementary mechanisms:
1. Reducing Liver Glucose Production
The liver continuously produces glucose (a process called gluconeogenesis). In Type 2 Diabetes, this process is overactive, contributing to high fasting blood sugar. Metformin's primary action is to suppress this hepatic glucose production, which is why it is particularly effective at lowering fasting blood glucose levels.
2. Improving Insulin Sensitivity
Metformin makes muscle and fat cells more responsive to insulin, allowing them to take up glucose more efficiently. This addresses the core problem in type 2 diabetes — insulin resistance.
3. Slowing Intestinal Glucose Absorption
Metformin modestly slows the absorption of glucose from the intestine after meals, contributing to lower post-meal blood sugar spikes.
What Metformin Does Not Do
Understanding metformin's limitations is as important as knowing its benefits:
- It does not cause hypoglycemia when used alone — because it does not stimulate insulin release, blood sugar cannot drop dangerously low from metformin alone
- It does not cause weight gain — unlike many older diabetes medications, metformin is weight-neutral or may cause modest weight loss
- It does not treat type 1 diabetes — metformin requires some residual insulin production to work
Dosing
Metformin is available in immediate-release (IR) and extended-release (ER/XR) formulations.
| Formulation | Starting Dose | Typical Maintenance | Maximum Dose |
|---|---|---|---|
| Immediate-release | 500 mg twice daily | 1,000 mg twice daily | 2,550 mg/day |
| Extended-release | 500–1,000 mg once daily | 1,500–2,000 mg once daily | 2,000 mg/day |
Always take metformin with food — this significantly reduces gastrointestinal side effects.
Side Effects
Common (Gastrointestinal)
The most common side effects are gastrointestinal and affect up to 30% of patients, especially when starting treatment:
- Nausea
- Diarrhea
- Stomach upset or cramping
- Metallic taste in the mouth
These effects are usually temporary and improve within 2–4 weeks. Starting at a low dose and gradually increasing (as prescribed) minimizes them significantly. Switching from immediate-release to extended-release formulation also reduces GI side effects for many patients.
Vitamin B12 Deficiency
Long-term metformin use reduces the absorption of vitamin B12 from the gut. This can lead to B12 deficiency over time, which may cause:
- Fatigue
- Numbness or tingling in hands and feet
- Cognitive changes
Recommendation: Ask your doctor to check your B12 level annually if you have been on metformin for more than 2 years.
Lactic Acidosis (Rare but Serious)
Lactic acidosis — a dangerous buildup of lactic acid in the blood — is a rare but serious risk associated with metformin. It is most likely to occur in patients with:
- Significant kidney impairment (metformin is contraindicated when eGFR < 30 mL/min/1.73m²)
- Severe liver disease
- Heart failure
- Situations of acute illness, dehydration, or contrast dye procedures
Symptoms include muscle pain, weakness, difficulty breathing, and abdominal discomfort. This is a medical emergency.
Drug Interactions
Metformin has relatively few drug interactions compared to other diabetes medications. The most important:
- Contrast dye (iodinated): Metformin should be held before and after procedures using IV contrast dye due to the risk of acute kidney injury and subsequent lactic acidosis. Your doctor will provide specific instructions.
- Alcohol: Heavy alcohol use increases the risk of lactic acidosis and should be avoided.
- Certain medications that affect kidney function (NSAIDs, ACE inhibitors in high doses) may require dose adjustment.
Who Should Not Take Metformin
Metformin is contraindicated in:
- Severe kidney disease (eGFR < 30 mL/min/1.73m²)
- Active liver disease or cirrhosis
- History of lactic acidosis
- Diabetic ketoacidosis
Metformin Beyond Diabetes
Metformin is being studied for a range of conditions beyond type 2 diabetes:
- Polycystic ovary syndrome (PCOS): Widely used off-label to improve insulin sensitivity and restore ovulation
- Prediabetes prevention: The Diabetes Prevention Program showed metformin reduced progression to type 2 diabetes by 31%
- Anti-aging research: Ongoing trials are investigating metformin's potential to slow aging-related processes
- Cancer prevention: Observational data suggests metformin users have lower rates of certain cancers, though causality is unproven
The Bottom Line
Metformin is one of the most well-studied, safe, and cost-effective medications in all of medicine. Its combination of efficacy, weight neutrality, low hypoglycemia risk, and cardiovascular safety data makes it the default starting point for type 2 diabetes management. Generic metformin costs as little as $4–$10 per month at most pharmacies.
If you have been prescribed metformin and are experiencing significant GI side effects, talk to your prescriber about switching to the extended-release formulation before discontinuing — this simple change resolves the problem for many patients.
This article is for informational purposes only. Always consult a licensed healthcare provider before starting or changing any medication.
Save up to 80% on this medication
Use a free RxGo discount card at 67,000+ pharmacies — no sign-up, no insurance needed.
About the Author
Dr. Sarah Chen, PharmD, BCPS
Clinical Pharmacist & Medical Reviewer
Dr. Sarah Chen is a board-certified pharmacotherapy specialist with over 12 years of clinical experience in hospital and ambulatory care settings. She specializes in cardiovascular pharmacotherapy, diabetes management, and drug interaction analysis.
View full profile on our Editorial Team page →Zova Health
Protect the Architecture · GLP-1 Protocol
Don't just lose weight. Preserve your health.
GLP-1 medications can cause up to 39% muscle loss alongside fat. Zova's evidence-based protocol — validated by Lancet Diabetes & Endocrinology 2024 — combines AI-powered leucine tracking, injection-day adaptive nutrition, and progressive resistance training to reduce that to just 8.7%.
No credit card. No commitment. Early access only.
Clinical validation:
Structured protein protocols preserved 78% more lean mass vs. standard GLP-1 use alone. — Lancet Diabetes & Endocrinology, 2024
Get the RxGo app — free prescription discounts on the go
Works at 67,000+ pharmacies · No membership needed
